We believe that fingerprinting the immune system can be a game-changer when it comes to improving the surgical journey for millions of patients. Combining innovative technologies with artificial intelligence, our multidisciplinary team of clinicians, engineers and scientists is focused on holistically improving the standard-of-care. Predicting the risk for complications before surgery is critical to allow personalization of pre-operative clinical interventions, surgical decision-making and improvement of surgical outcomes. 30% of major surgeries result in complications within 30 days postoperatively, such as infection or pneumonia, and even death. More than 40% of 65 years-old or older patients will develop either cognitive or mood disorders that can last months after orthopaedic or cardiac surgeries.

Surge2Surgery is grounded in more than seven years of clinical, basic science, and translational research led by our team at Stanford University. Our test combines single-cell assessment of the immune system before surgery with clinical data available through Electronic Health Records (EHR) using a proprietary machine learning algorithm. Individual immune systems are comprehensively assessed from a single blood sample obtained before surgery and analyzed using mass cytometry. Our method allows us to mimic surgical trauma in a test tube with a small amount of blood containing millions of immune cells before surgery.We use this technique to understand exactly how every immune cell in your body is responding to the trauma to precisely predict postoperative outcomes.